Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 219-552-0 | CAS number: 2460-77-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
2,5 -di-tert-butyl-p-benzoquinone was tested for its possible skin corrosion potential using a three-dimensional Reconstructed Human Epidermis model, EpiSkin, through topical application. The test was performed using OECD 431 guideline. After 3 min, 60 min and 240 min exposures with the test item, the observed cell viability was approximately 100%.
The study indicate that the test item 2,5 -di tertiary butyl 1,4 -benzoquinone is non-corrosive in this in vitro skin corrosion test using reconstructed human epidermis under the conditions of testing employed.
The substance was tested for its possible skin irritation potential using a three-dimensional Reconstructed Human Epidermal model, EpiSkin. The mean relative tissue viability for 2,5-di-tert-butyl-1,4-benzoquinone was above 50% and hence it is non-irritant under the experimental conditions described.
Eye irritation was potential was investigated according to prediction model described in test guideline OECD 492. As the test item-treated tissues showed viability of > 60.0% relative to negative control-treated tissue viability, the test item, 2,5 - di-tert-butyl-1,4 -benzoquinone, was concluded to be a non-irritant (NI).
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin corrosion: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 16 Aug 2017- 21 Nov 21 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 431 (In Vitro Skin Corrosion: Reconstructed Human Epidermis (RHE) Test Method)
- GLP compliance:
- yes (incl. QA statement)
- Specific details on test material used for the study:
- EpiSkin kit from SkinEthic Laboratories, France.
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- Source of the test system: SkinEthic Laboratories, France.
- Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- 20 mg
- Duration of treatment / exposure:
- 3, 60 and 240 min
- Number of replicates:
- 2
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 3 min exposure
- Value:
- 153.15
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 60 min exposure
- Value:
- 105.75
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 240 minute exposure
- Value:
- 94.701
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test item 2,5-di tertiary butyl 1,4-benzoquinone is non-corrosive in the EpiSkin in vitro skin corrosion model.
- Executive summary:
The test item was tested for its possible skin corrosion potential using a three-dimesional Reconstructed Human Epidermis model, EpiSkin, through topical application. After 3 min, 60 min and 240 min exposures with the test item, the observed cell viability was 153% and 106% and 95%, respectively.
The positive control had a mean cell viability of 4.44% after 240 -minutes exposure. The absolute mean OD570 of the negative control tissue was 0.493625, 0.61595 and 0.548225 for the 3 -minute, 60 -minutes and 240 -minutes exposures, respectively. The results of the controls indicate that the test system functioned properly.
The study indicate that the test item 2,5 -di tertiary butyl 1,4 -benzoquinone is non-corrosive in this in vitro skin corrosion test using reconstructed human epidermis under the conditions of testing employed.
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 16 Aug 2017-24 Nov 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- GLP compliance:
- yes (incl. QA statement)
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Cell source:
- skin obtained from plastic surgery from multiple donors
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- EpiSkin from SkinEthic Laboratories, Lyon, France. Batch nro. 17-EKIN-044. After receipt, 13 epidermis units were transferred to 12-well plates containing 2 ml of pre-warmed maintenance medium and incubated in a CO2 incubator for 1 hour 15 minutes.
Cell viability was assessed by measuring mitochondrial activity. The tissues were incubated with MTT solution. MTT was reduced by succinated dehydrogenase into a blue formazan precipitate in the mitochondria of living cells. Prior to treatment in the irritation assay, the test item was evaluated for its intrinsic color or ability to become colored in contact with water. Prior to treatment in the irritation assay, the test item was checked for possible direct MTT reduction by exposing it in direct contact with the MTT solution.
After exposures the epidermal units were dried carefully and prefilled with MTT-solution and plated were incubated for 3 hours at 37oC in a carbon dioxide incubator with 5% CO2. After incubation with MTT, the epidermis units were placed on an absorbent paper to dry the tissues. Total biopsy was made by using a biopsy puch. Epidermis was separated from the collagen matrix using forceps and bothe parts were placed in pre-labaled microtubes and extracted with 500 ul of acidic isopropanol. Tubes were stored at room temperature for 4 hours.
About 200 ul sample from each tube was transferred into the wells of a labeled 96-well flat bottom plated (2 wells/epidermis unit) and the amount of extracted formazan was determined spectrophotometrically at 570 nm in duplicated with TECAN Infinite M200 Microplated reader, using acidified isopropanol solution as the blank. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- 10 mg
- Duration of treatment / exposure:
- 15 min
- Duration of post-treatment incubation (if applicable):
- 42 hours
- Number of replicates:
- Three
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- Mean value
- Value:
- 133
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- The absolute mean OD570 of the negative control tissues was 0,5694. The positive control has a mean cell viability of 0,03865% after 15 minutes exposure, indicating that the test system functioned properply.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The mean relative tissue viability for the test item, 2,5-di-tert-butyl-1,4-benzoquinone was above 50% and hence it is non-irritant under the experimentl conditions described.
- Executive summary:
The test item, 2,5 -di-tert-butyl-1,4 -benzoquinone was tested for its possible skin irritation potential using a three-dimensional Reconstructed Human Epidermal model, EpiSkin, through topical application for 15 minutes.
The test item is in solid form and was applied directly on the top of the skin tissues at 10 mg/tissue, along with 5ul of distilled water and exposed for 15 minutes.
Ten microliters (10 ul) pf PBS and 10 ul of 5% aqueous SDS used as the negative and positive controls, respectively.
After approximately 42 -hour post-incubation perid, irritation potential of 2,5 di-tert-butyl-1,4 -benzoquinone was evaluated by assessing the cytotoxic (irritancy) effect. Cytotoxicity is expressed as the reduction of mitochondrial dehydrogenase activity measured by formazan production from MTT at the end of the treatment.
Skin irritation is expressed as the ability of the test item to reduce the cell viability after exposure to the test item. The relative mean tissue viability obtained after 15 minutes treatment with the test item was compared to the negative control tissues. The mean relative tissue viability for the test item, 2,5-di-tert-butyl-1,4-benzoquinone was above 50% (133%) and hence it is non-irritant under the experimentl conditions described.
The absolute mean OD570 of the negative control tissues was 0.5694. The positive control has a mean cell viability of 0.0385% after 15 minutes exposure, indicating that the test system functioned properly.
The study indicated that the test item 2,5-di-tert-butyl-1,4-benzoquinone is non-irritant in in vitro skin irritation test using Reconstructed Human Epidermis under the conditions of testing employed.
Referenceopen allclose all
Table 1. OD values of individual epidermis units, 3 min exposure
Absorption, OD570 |
||
R1 | R2 | |
Negative control | 0,49600 | 0,49125 |
Test item | 0,75120 | 0,76080 |
Negative control (color) | 0,00460 | - |
Non-specific color control | 0,00480 |
able 2. OD values of individual epidermis units, 60 min exposure
Absorption, OD570 |
||
R1 | R2 | |
Negative control | 0,61720 | 0,61470 |
Test item | 0,65080 | 0,65190 |
Negative control (color) | 0,00585 | 0,00550 |
Non-specific color control | 0,00565 | 0,00640 |
able 3. OD values of individual epidermis units, 240 min exposure
Absorption, OD570 |
||
R1 | R2 | |
Negative control | 0,54845 | 0,5480 |
Positive control | 0,02695 | 0,02180 |
Test item | 0,52150 | 0,51685 |
Negative control (color) | 0,00225 | 0,00190 |
Non-specific color control | 0,00205 | 0,00350 |
Table 1. Mean OD values of individual epidermis units.
Absorption (OD570) |
|||
R1 | R2 | R3 | |
Negative control | 0,6064 | 0,6114 | 0,61355 |
Positive control | 0,0771 | 0,0799 | 0,0821 |
Test item | 0,78185 | 0,80515 | 0,80305 |
Negative control (color) | 0,0449 | 0,0447 | - |
Non-specific color control | 0,0494 | 0,0586 | - |
Blank (isopropanol) OD value (mean of 6 replicate values): 0.04105.
OD: optical density
Table 2. True OD values of individual epidermis units.
Absorption (OD570) |
|||||
R1 | R2 | R3 | Mean | SD | |
Negative control | 0,56535 | 0,57035 | 0,5725 | 0,5694 | 0,0036 |
Positive control | 0,03605 | 0,03885 | 0,04105 | 0,038565 | 0,003 |
Test item | 0,7408 | 0,7641 | 0,762 | 0,75563 | 0,013 |
Negative control | 0,00385 | 0,00365 | - | 0,00375 | - |
Nonspecific color control | 0,00835 | 0,01735 | - | 0,01295 | 0,007 |
OD= optical density
True OD value= OD Raw-OD Blank
Note: the OD values of the concurrent negative control tissues set up along with NSC control were not used in calculation.
Table 3. Individual tissue viability of epidermis units.
% Individual Viability |
|||||
R1 | R2 | R3 | Mean | SD | |
Positive control |
6,33 | 6,82 | 7,21 | 6,79 | 0,441 |
Test item | 130,10 | 134,19 | 133,82 | 132,70 | 2,262 |
Non-specific color control | 1,46 | 3,08 | - | 2,27 | 1,146 |
Negative control mean: 0,5694
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 8 Sep 2017- 28 Nov 2017
- Reliability:
- 1 (reliable without restriction)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- GLP compliance:
- yes (incl. QA statement)
- Species:
- human
- Details on test animals or tissues and environmental conditions:
- The test system used iwas Reconstructed Human Cornea-like Epithelium (RhCE). RhCE cell construc, EpiOcular TMt is a nonkeratinized epithelium composed of normal human keratinocytes in a three-dimensional structure. It mimics the corneal epithelium with progressively stratified but not cornified cells.EpiOcularTM tissues were procured from MatTek In Vitro Life Science Laboratories, Slovakia. Cat no. OCL-200-EIT. Lot no. 27005.
- Vehicle:
- other: MTT
- Controls:
- yes
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- 50 mg test item in 1 ml of MTT
- Duration of treatment / exposure:
- 30 minutes
- Duration of post- treatment incubation (in vitro):
- 18 hours
- Details on study design:
Test Material Exposure (Day 1)
a. Test item exposure: After the 30±2 minutes Ca++Mg++Free-DPBS pretreatment, 50 μL each of negative control, positive control and 50 mg of test item tested by applying topically on the EpiOcular™ tissues so as to cover the upper surface.
b. The tissue insert were gently tapped to make sure the test item/controls spreads all over the surface of the tissue. Tissues were incubated at 37±1oC, 5% CO2 and humidified atmosphere for 6 ± 0.25 hours.
Rinsing
At the end of treatment time (6 ± 0.25 hours), controls/test item were removed by extensively rinsing the tissues with Ca++Mg++-free D-PBS (brought to room temperature), as described in detail below.
Three sets of sterile beaker (150 mL capacity) containing 100 mL of Ca++Mg++ - free DPBS were prepared for each treatment (test item and controls tested). The inserts containing the tissue was lifted out of the medium by grasping the upper edge of the plastic "collar" with fine forceps, two tissues were rinsed at a time by holding replicate inserts together by their collars using forceps. Care was taken not to damage the tissues by the forceps. The test item and controls were decanted from the tissue surface onto a clean absorbent material and the tissues were dipped into the first beaker of DPBS, swirled in a circular motion for approximately 2 seconds, lifted out and the liquid was decanted back into the container. This process was performed for two additional times in the first beaker. The tissues were then rinsed in the second and third beakers of DPBS three times each in the same manner. Finally, any remaining liquid was decanted onto the absorbent material.
MTT Viability Assay
Post treatment incubation of 18 ± 0.25 hours, MTT assay was performed.
a) 300 μL of the MTT solution (1 mg/mL) was added to each designated well of a pre-labeled 24-well plate.
b) Each tissue insert was removed from the 6-well plate and gently blotted on absorbent material. The tissues were placed into the 24-well plate containing 0.3 mL of MTT solution. Once all the tissues were placed into the 24-well plates, the plates were incubated for 180±10 minutes at Standard Culture Conditions.
c) Each tissue insert was removed from the 24-well plate after 180 ± 10 minutes; the bottom of the insert was blotted on absorbent material, and then transferred to a pre-labeled 6-well plate containing 2 mL isopropanol in each well so that no isopropanol is flowing into the insert. Plates were placed on an orbital plate shaker and shaken for 2 hours at room temperature. At the end of the extraction period, the tissues were not pierced and the liquid within each tissue insert was decanted into the well from which it was taken.
d) The extract solution was mixed and two 200 μL aliquots were transferred to the appropriate wells according to the plate map. 200 μL of isopropanol was added to the wells designated as blanks. The absorbance at 570 nm of each well was read in microplate reader.
After rinsing, the tissues were immediately transferred and immersed in 5 mL of previously warmed assay medium (room temperature) in a pre-labeled 12-well plate for 25 ± 2 minutes at room temperature to facilitate the removal of any residue test item.
At the end of the Post-Soak immersion, each tissue was removed from the assay medium, the medium was decanted off the tissue, and the tissue construct was blotted on absorbent material. The tissues were then transferred to the appropriate wells of pre-labeled 6-well plate containing 1 mL of warm assay medium. The tissues were incubated for 18 ± 0.25 hours at standard culture conditions.
Calculation for Viability
Percentage viability was calculated for two relating tissues of controls and test item relative to the negative control (100 %). Viability % = corrected test item OD corrected mean negative control OD x 100
If the difference between two relating tissues is >20% the test is considered as non-qualified. Mean test item viability was calculated and the test item was classified according to the prediction model ( Refer section 8.5).- Irritation parameter:
- in vitro irritation score
- Run / experiment:
- The mean tissue viability (%)
- Value:
- 124
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- 100
- Positive controls validity:
- valid
- Remarks:
- 2.15
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- Acceptance Criteria
• The negative control OD was in between > 0.8 and < 2.5.
• The mean tissue viability of the positive control was < 50% compared to the negative control.
• The variability between tissue replicates of test item and control substances were within the accepted limits.
o The difference of viability between two tissue replicates was less than 20% for negative control, test item and positive control treated tissue - Interpretation of results:
- GHS criteria not met
- Conclusions:
- Test item-treated tissues showed viability of > 60.0% relative to negative control-treated tissue viability, thus the test item 2, 5- di- tert-butyl -,4- benzoquinone (YAPOX 2255) was concluded to be a non-irritant (NI).
- Executive summary:
A guideline compliant eye irritation study (OECD 492) –in vitro eye irritation in Reconstructed Human Cornea-like Epithelium (RhCE)) was conducted. Aim of the study was to examine the acute eye irritation potential of the test item by measurement of its cytotoxic effect on the EpiOcular™ cornea epithelial model. The EpiOcular tissue construct is a nonkeratinized epithelium prepared from normal human keratinocytes (MatTek).
In this assay, the test item was applied to the surface of the cornea epithelial construct for 30 minutes. After exposure period, each tissue was extensively rinsed, and the tissue was allowed to express the resulting damage. Two construct tissues were used for the treatment with test item and for negative and positive controls. The MTT assay was performed to determine tissue viability. The tissues were transferred in the 24-wells plate containing MTT medium and incubated in a humidified atmosphere for 3 hours. After incubation the blue formazan salt formed was extracted in isopropanol and the optical density of extracted formazan was determined using a spectrophotometer at 540 nm. Validity of the test method was ascertained by positive control (methyl acetate) and negative control (deionized sterile water). The tissue viability met the acceptance criterion as the mean OD of negative control was in between > 0.8 and < 2.5. The positive control met the acceptance criterion as the viability of culture treated by methyl acetate was 39% (less than 60%).The viability of culture treated by 2,5 -di-tert-butyl-1,4 -benzoquinone was 124 %. Therefore, 2,5 -di-tert-butyl-1,4 -benzoquinone
is considered to be non-irritant to the eye.
Classification of test items as irritants and non-irritants was carried according to prediction model described in test guideline OECD 492. As the test item-treated tissues showed viability of > 60.0% relative to negative control-treated tissue viability, the test item, 2,5- di-tert-butyl-1,4 -benzoquinone, was concluded to be a non-irritant (NI).
Reference
Interpretation of results and prediction model
Interpretation of results was carried out according to prediction model described below.
Prediction model
If the test item-treated tissue viability is > 60.0% relative to negative controltreated tissue viability, the test item is labeled as non-irritant.
If the test item-treated tissue viability is ≤ 60.0% relative to negative controltreated tissue viability, the test item is labeled as irritant.
Table 1. Tissue viabilities.
Item | Tissue Viability 1 | Viability Tissue 2 | Mean 1 & 2 | Diff 1 &2 | Classification | ||||
Ali 1 | Ali 2 | Mean 1 | Ali 1 | Ali 2 | Mean 2 | ||||
Negative control | 97,82 | 96,18 | 97,00 | 103,07 | 102,93 | 103,00 | 100,00 | 6,00 | Non-irritant |
Positive control | 40,14 | 39,28 | 39,71 | 36,54 | 38,58 | 37,56 | 38,63 | 2,15 | Irritant |
Test item | 119,11 | 118,02 | 118,57 | 128,27 | 130,84 | 129,56 | 124,06 | 10,99 | Non-irritant |
Ali: Aliquot, Diff: difference of viability between 2 tissues.
Table 2. OD values of individual epiocular tissues.
Item | OD570 nm Values |
|||
Tissue 1 |
Tissue 2 |
|||
R1 | R2 | R1 | R2 | |
Negative control | 1,0586 | 1,0416 | 1,1133 | 1,1118 |
Positive control | 0,4586 | 0,4494 | 0,4208 | 0,4421 |
Test item | 1,2802 | 1,2689 | 1,3756 | 1,4023 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Additional information
Justification for classification or non-classification
The results of the key study studies do not indicate the substance to be classified for skin irritant according to CLP Regulation 1272/2008.
The result of the key study does not indicate the substance to be classified for eye irritant according to CLP Regulation 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.